Navigation Links
Sense4Baby, Inc. Names Dr. Jessica Grossman President and CEO

SAN DIEGO, April 23, 2013 /PRNewswire-USNewswire/ -- Sense4Baby, Inc., a startup developing a portable, remote, wireless maternal/fetal heart rate monitoring system to perform non-stress testing for mothers in high-risk pregnancies, announced Jessica Grossman , M.D., as its new president and chief executive officer. The company also announced it has received $4 million in funding from the West Health Investment Fund.

(Photo: )
(Logo: ) 

Dr. Grossman brings a strong history and knowledge of women's health and the medical device industry to lead Sense4Baby, Inc.'s mission of advancing maternal and neonatal access to health care. Most recently, Dr. Grossman was a medical director at Ethicon Endo-Surgery, a Johnson & Johnson company, where she supported one of the surgical instrument franchises.  Dr. Grossman trained as an obstetrician/gynecologist at Pennsylvania Hospital.

"Dr. Grossman's medical and professional experience will help guide Sense4Baby, Inc.'s clinical and commercial success," said Nicholas Valeriani , chairman of the board of Sense4Baby, Inc. and chief executive officer of the West Health Institute.  "Sense4Baby, Inc. demonstrates how West Health's family of entities can work together to help lower the cost of health care. The company licensed a technology invented at the Institute for the public good, is housed at the West Health Incubator and received capital from the Investment Fund with the ultimate goal of bringing a new, cost-lowering and patient-centered technology to market."

"High-risk pregnancies put a tremendous strain on both health care systems and families," said Dr. Grossman. "The potential for remote monitoring with the Sense4Baby™ system is the first step toward technology that could lower costs and improve health care for both mothers and infants."

In the past ten years, Dr. Grossman served in numerous positions at many startup medical device companies. Dr. Grossman was also the founder, president and member of the board of directors at Gynesonics, an early stage medical device company focused on minimally invasive solutions for women's health, where she raised more than $20 million in venture capital financing and invented and helped develop the first intrauterine, ultrasound-guided radiofrequency ablation device for fibroid tumors.

Dr. Grossman holds numerous patents and has published several peer-reviewed articles. She earned her M.D. at Thomas Jefferson University and graduated with honors from Brandeis University. She also performed research at the Beth Israel Deaconess Medical Center, one of the teaching hospitals of Harvard Medical School. Dr. Grossman currently serves on the board of advocates for Americans for the United Nations Population Fund (UNFPA), where she focuses on education and fundraising for underserved women and children. Dr. Grossman also serves on the board of directors of Medicines 360, a nonprofit pharmaceutical company that addresses unmet needs of women by developing innovative, affordable and sustainable medical solutions.

Designed from the ground up at the West Health Institute (watch video), the Sense4Baby system is an innovative, proprietary, portable wireless maternal/fetal monitor and uterine contraction monitor device that uses custom sensors, software and hardware connected to a cellular network to address high risk pregnancies. The Sense4Baby system is pending marketing clearance by the U.S. Food and Drug Administration.

In September 2012, Sense4Baby, Inc., one of the initial licensees of technology developed by the West Health Institute, became the first resident of the West Health Incubator after receiving a funding commitment from the West Health Investment Fund, a prerequisite of residency.

Financial returns from the West Health Investment Fund will sustain the mission of West Health's philanthropic endeavors to discover and develop innovative patient-centered solutions to lower the cost of health care delivery.

Sense4Baby, Inc. is a startup medical device company developing a portable, wireless maternal/fetal monitoring system for remote monitoring of mothers with high-risk pregnancies. With core technology developed at the West Health Institute, Sense4Baby, Inc. is creating technologies that shift the site of care for women with high-risk pregnancies which may that help lower costs and increase comfort for patients. Learn more at

SOURCE Sense4Baby, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Second ISPE-FDA Event Attracts Top Names, Features Release of Drug Shortage Survey Results
2. Hospira Names Matthew R. Stober Senior Vice President of Operations
3. Covagen Names Elias Papatheodorou Chief Business Officer
4. IDEXX Laboratories Names Jeffrey Fiarman Executive Vice President and General Counsel
5. Collegium Pharmaceutical Names Douglas Carlson to Vice President of Business Development
6. Quest Diagnostics Names Sukumar Nagendran, M.D., Vice President, Medical Affairs
7. Halozyme Therapeutics Names Matt Posard to Board of Directors
8. Array BioPharma Names Michael N. Needle, M.D. As Chief Medical Officer
9. Bausch + Lomb Names Robert Bertolini President And Chief Financial Officer
10. Tandem Diabetes Care Names Lonnie Smith As Chairman Of The Board
11. PeriGen, Inc. Names American Journal of OBGYN Editor-In-Chief Thomas J. Garite MD, Chief Clinical Officer
Post Your Comments:
(Date:11/25/2015)... DUBLIN , Nov. 25, 2015 ... global pharmaceutical company, and Rugen Therapeutics, a start-up ... treatments for unmet CNS disorders and funded by ... that they have entered into an exclusive collaboration ... therapies for Autism Spectrum Disorders (ASD) and Obsessive ...
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ ... "Company") (NYSE: MR ), a ... medical devices worldwide, today announced that ... general meeting of shareholders at the ... Grand Century, 193 Prince Edward West Road, ...
(Date:11/25/2015)... , November 25, 2015 /PRNewswire/ ... announced the addition of the  "Global ...  report to their offering.  ... the addition of the  "Global Drug ...  report to their offering.  --> ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... November 24, 2015 , ... Dr. Todd S. Afferica, a noted general ... of his patients. Dr. Afferica now uses the BIOLASE WaterLase iPlus 2.0™ in many ... the doctor uses other traditional cutting tools, such as the scalpel and high-speed drill, ...
(Date:11/24/2015)... CA (PRWEB) , ... November 24, 2015 , ... ... sizes, has launched their Black Friday sale a week early, offering 40% off ... to transform the intimate apparel industry through both mobile fit technology and the ...
(Date:11/24/2015)... ... 24, 2015 , ... The hospitals and health systems on ... orthopedic care. They have received recognition for excellence from various reputable organizations in ... Becker's Hospital Review selected hospitals for inclusion based on national rankings and awards ...
(Date:11/24/2015)... Berkeley, California (PRWEB) , ... November 24, 2015 ... ... Brillouin Energy's LENR HHT Bolier Reactor System. Brillouin is the developer of renewable ... on controlled low energy nuclear reactions (“LENR”), announced today that its WET™ and ...
(Date:11/24/2015)... ... November 24, 2015 , ... The American Association of Poison ... poison centers through donations on Tuesday, Dec. 1, 2015. Since 2012, the Tuesday ... inspires people to collaborate in improving their local communities and help give back ...
Breaking Medicine News(10 mins):